insights_auto
Why is SABS down 3,44%?
Dive Deeperchevron_right
SABS:NASDAQ
SAB Biotherapeutics Inc
2,81 US$
arrow_downward
-3,44%(-0,10) 1D
2,81 US$
0,00% (0,00)
bedtimeAfter hours
Closed: 20 ნოე, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABS...
Open
2,79 US$
High
2,88 US$
Low
2,64 US$
Mkt. cap
253,15 მლნ.
Avg. vol.
709,90 ათ.
Volume
874,57 ათ.
52-wk high
5,15 US$
52-wk low
2,44 US$
EPS
-0,93 US$
Beta
0,67
Shares outstanding
90,09 მლნ.
No. of employees
86
Open
2,79 US$
High
2,88 US$
Low
2,64 US$
Mkt. cap
253,15 მლნ.
Avg. vol.
709,90 ათ.
Volume
874,57 ათ.
52-wk high
5,15 US$
52-wk low
2,44 US$
EPS
-0,93 US$
Beta
0,67
Shares outstanding
90,09 მლნ.
No. of employees
86
News stories
From web sources and news partners
Traders Union
·
1 საათის წინ
VIX fear index hits highest level since April 2025 as S&P 500 plunges
Nacionale
·
5 საათის წინ
Is the stock market down for the year? Only the Nasdaq; the S&P 500 and Dow are barely up for 2026
FXStreet
·
11 საათის წინ
Dow Jones Industrial Average drops for a fifth day as AI rout widens
Big News Network.com
·
54 წუთის წინ
S&P 500 earnings growth projected to slow to 11% in 2027 as AI investment impulse peaks: Goldman Sachs
About SAB Biotherapeutics Inc
CEO-
Employees86
Founded2014
Headquartersმაიამი-ბიჩი, ფლორიდა, ამერიკის შეერთებული შტატები
SectorHealth Care
Industry-
Websitesab.bio